LVI

Dr. Ryan M. Jouett, DDS, LVIM, FICOI from Radiant Exceptional Dentistry Has Become One of Only 25 Master Dentists in the World

Retrieved on: 
Tuesday, April 23, 2024
Insurance, Dentist, DDS, LVI, Dentures, Patient, Headache, Jaw, Multimedia, CPAP, Dentistry

Dr. Ryan M. Jouett, DDS, LVIM, FICOI has become one of only 25 Master Dentists in the world as a graduate of LVI.

Key Points: 
  • Dr. Ryan M. Jouett, DDS, LVIM, FICOI has become one of only 25 Master Dentists in the world as a graduate of LVI.
  • Benefits to the patient can include reduction of headaches and opening of the airway as an alternative to CPAP.
  • Dr. Jouett is a co-principal of Radiant Exceptional Dentistry in Bryan, Texas along with Dr. Michael K. Reece, DDS, LVIM, FICOI who is also a LVI Master Dentist making them the only dental practice in the world with two Master Dentists.
  • Radiant Exceptional Dentistry focuses on six disciplines including Cosmetic/Non-Surgical Facelift, Sleep Apnea, Headaches/TMJ, New You Dentures, Teeth-In-A-Day™ and Fearless Sedation Dentistry.

Ibex Medical Analytics Wins Edison Bronze Award for AI-Powered Breast Cancer Diagnostics Solution

Retrieved on: 
Friday, April 19, 2024
Protein, Cell, Laboratory, Breast, HER2, Woman, Hospital, AI, Breast cancer, TILS, Immunohistochemistry, IHC, Knowledge, Oncology, Entrepreneurship, LVI, Ibex, Marie Cassidy, Patient, Edison Awards, Neoplasm, Diagnosis, Medical imaging

BOSTON, April 19, 2024 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced that Galen™ Breast HER2 has been named a bronze winner of the 2024 Edison Awards in the Diagnostic Technologies category. The awards, named after inventor Thomas Alva Edison, honor companies and innovations that are shaping the future, creating a positive impact in the world and improving lives.

Key Points: 
  • BOSTON, April 19, 2024 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced that Galen™ Breast HER2 has been named a bronze winner of the 2024 Edison Awards in the Diagnostic Technologies category.
  • Breast cancer impacts one in eight American women and as such, accurate and timely diagnosis is key to guiding treatment decisions and improving survival rates.
  • Ibex's Galen Breast HER2 is an AI-powered scoring solution that helps pathologists assess HER2 expression in tumors to support identification of breast cancer patients eligible for targeted therapies.
  • The award highlights our innovative approach in developing AI-powered tools such as Galen Breast HER2 that set the new standard in breast cancer diagnosis."

GALLS® Strengthens Commitment to Military and Defense with Strategic Acquisition of LVI

Retrieved on: 
Monday, February 19, 2024
Acquisition, Woman, Air force, Defense, Army, United States Navy, Clothing, Navy, USMC, DLA, LVI

LEXINGTON, Ken., Feb. 19, 2024 /PRNewswire/ -- GALLS®, the nation's leading supplier serving America's public safety and military professionals, proudly announces the completion of a major acquisition of LVI. LVI, a Galls Company, is a multi-faceted Third Party Logistics (3PL) Partner with over 28 years of experience supporting the Defense Logistics Agency (DLA), Army, Navy, USMC, and Air Force with clothing and textile functions, military logistics, and supply chain solutions to ensure mission-critical combat readiness. The acquisition marks a significant stride for GALLS as it seeks to expand its foothold in the military and defense sector.

Key Points: 
  • LEXINGTON, Ken., Feb. 19, 2024 /PRNewswire/ -- GALLS ®, the nation's leading supplier serving America's public safety and military professionals, proudly announces the completion of a major acquisition of LVI.
  • The acquisition marks a significant stride for GALLS as it seeks to expand its foothold in the military and defense sector.
  • Mike Fadden, CEO of GALLS, explained, "The recent acquisition of LVI aligns seamlessly with our strategic objectives, bolstering our commitment to the men and women in uniform.
  • GALLS recognizes the value of LVI's expertise in 3PL military logistics services, enabling the company to broaden its service capabilities.

COOPER KUPP AND LOS ANGELES RAMS JOIN FORCES WITH RENOWNED CHEFS TO RAISE FUNDS FOR THE LOS ANGELES REGIONAL FOOD BANK AND COMBATING FOOD INSECURITY

Retrieved on: 
Tuesday, September 12, 2023
Volunteering, NFL, Food, ABC7, Capital Area Food Bank, Meal, Silver, Super Bowl LVI, Food bank, Bank of America, Local, LA, History of the Los Angeles Rams, Bank, SoFi Stadium, Hunger, Family, Taste, LVI, Furniture, Fast food, Rams

This funding will help the Los Angeles Regional Food Bank distribute hundreds of thousands of nutritious meals across LA County, substantially impacting the ongoing battle against hunger.

Key Points: 
  • This funding will help the Los Angeles Regional Food Bank distribute hundreds of thousands of nutritious meals across LA County, substantially impacting the ongoing battle against hunger.
  • Held at the renowned SoFi Stadium, home to Super Bowl LVI and the Los Angeles Rams, this year's event garnered significant support from steadfast Food Bank allies, including Don Lee Farms and Bank of America.
  • Kupp has supported local efforts to combat food insecurity alongside the Food Bank and numerous Rams players, cheerleaders, and front office staff.
  • Please credit the Los Angeles Regional Food Bank.

Ibex Launches Galen™ Breast HER2, Supporting Improved Biomarker Scoring in Breast Cancer Patients

Retrieved on: 
Thursday, September 7, 2023
ER, PR, Ibex, HER2, Marie Cassidy, Cell, H&E, Biomarker, AstraZeneca, Reproducibility, IHC, Breast, TEL, Congress, TILS, Protein, Hospital, MD, Breast cancer, Patient, Laboratory, Daiichi Sankyo, European, Immunohistochemistry, AI3, AI, Oncology, Malignancy, MD Anderson Cancer Center, LVI, 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, Medical device, Medical imaging, Birth control, Nature, Pathology

TEL AVIV, Israel, Sept. 7, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced the launch of Galen™ Breast HER2, an AI-powered solution that aids pathologists in setting a higher standard for accurate and reproducible HER2 (human epidermal growth factor receptor 2) scoring in breast cancer patients.

Key Points: 
  • HER2, one of the proteins responsible for division and proliferation of breast cancer cells, is expressed in many breast tumors and its accurate assessment is critical for identifying patients who are likely to benefit from HER2-directed therapies.
  • Traditionally, pathologists evaluate HER2 in tumor samples visually, which may result in varied interpretations as scoring is semi-quantitative and thus somewhat subjective1.
  • Galen Breast HER2 was developed and validated by Ibex in collaboration with AstraZeneca and Daiichi Sankyo .
  • Information about Galen Breast HER2 and Galen Breast will be available at the 35th European Congress of Pathology in Dublin, Ireland, between September 9-13 (Ibex Medical Analytics - booth number 23).

XiFin Launches New Lab Volume Index (LVI): Delivers Deeper Insights in Post-Pandemic Diagnostic Testing

Retrieved on: 
Wednesday, August 30, 2023
Software, Practice Management, Telemedicine, Virtual Medicine, General Health, Health, Artificial Intelligence, Health Technology, Technology, UBS, Workflow, RCM, Pathology, Prenatal testing, Intelligence, Multimedia, COVID, Managed care, Holiday, Investment, Laboratory, Webcast, Engineering, Pain management, Toxicology, Genetic testing, Internationalized domain name, NYSE, LVI, Microbiology, Cryptocurrency, Pharmaceutical industry

The LVI insights and trends are derived from claims transaction data from within the award-winning XiFin RPM platform .

Key Points: 
  • The LVI insights and trends are derived from claims transaction data from within the award-winning XiFin RPM platform .
  • For example, if the Lab Volume Index is selected for molecular and genetic, it shows the testing volume of all molecular and genetic testing, irrespective of whether it was performed at a hospital lab, a clinical lab, one that primarily does pain management and toxicology, or a lab specializing in molecular testing.
  • The enhanced XiFin Lab Volume Index also features a new user-selectable baseline for 2019 -2022, making it possible to compare the time going forward including annually.
  • Because the COVID volume is historically significant, the original XiFin Lab Volume Index was measured weekly to trend the surges and lulls that happened quickly during the pandemic.

Nathan's Famous, Inc. Chooses SOCi as Platform of Record to Power Local Visibility

Retrieved on: 
Thursday, August 10, 2023
Cloud, Database, Marketing, Nathan's Famous, SEO, Restaurant, Capital, Risk, SAN, LVI, Online shopping, Retail, Listing

SAN DIEGO, Aug. 10, 2023 /PRNewswire/ -- SOCi Inc., the leading CoMarketing Cloud for multi-location enterprises, will become Nathan's Famous, Inc.'s central platform to enhance local visibility, bolstering the brand's presence within local communities and maximizing revenue potential for franchise and corporate locations.

Key Points: 
  • , the leading CoMarketing Cloud for multi-location enterprises, will become Nathan's Famous, Inc. 's central platform to enhance local visibility, bolstering the brand's presence within local communities and maximizing revenue potential for franchise and corporate locations.
  • This enables Nathan's to automate and scale their localized marketing efforts, leading to improved local visibility, customer engagements, and revenue growth for both franchisees and corporate-owned locations.
  • "Recognizing the significant opportunities for enhanced local visibility across the restaurant industry, our team at SOCi provides our partners with a clear path forward for enterprises to seize control of their local visibility," said David Marler, Chief Customer Officer, SOCi.
  • To learn more about how SOCi is helping restaurant brands like Nathan's drive industry leading results, visit www.meetsoci.com .

'Ghosting' Customers Online Costs Retailers a Staggering $2.4 Billion Annually

Retrieved on: 
Thursday, May 18, 2023
Communication, Feedback, CMO, Pet Supplies Plus, Behavior, Ghosting, Capital, SAN, AI, Wal-Mart: The High Cost of Low Price, Social media, LVI, Automation, Retail, Online shopping, Invisibility

SAN DIEGO, May 18, 2023 /PRNewswire/ -- SOCi Inc., the leading comarketing cloud for multi-location enterprises, today unveiled data from its 2023 Local Visibility Index (LVI) detailing how retailers are "ghosting" more than half of all customers online when they give feedback, ask questions or leave reviews. This striking finding results in a $2.4 billion annual loss for the U.S. retail industry.

Key Points: 
  • "When retailers ignore their customers online, they inadvertently send a message that the customer experience isn't a priority.
  • By actively engaging with customers and being responsive, retailers can optimize search engine rankings, supporting brand awareness and in-store sales.
  • "Addressing online customer feedback – ranging from questions to reviews – should be an integral component of a retailer's overall omnichannel digital marketing strategy," added Ho.
  • "Thankfully, AI and automation present a game-changing opportunity for retailers and marketers to tackle the issue of ghosting customers online.

Technicolor Creative Studios: 2022 Full Year Results and business update

Retrieved on: 
Friday, March 10, 2023
Meta, NetEase, Top Gun, Creativity, Dardenne, Top Gun: Maverick, Documentation, LVI, Commercial Court, Visual Effects Society Award for Outstanding Animated Character in a Photoreal Feature, Technicolor Creative Studios, Warner Bros. Interactive Entertainment, Animation, UPON, Baz, Thirteen Lives, Recollections of Full Years, Electronic Arts, Prix, Rockstar Games, Growth, MPC, Sega, Cannes Film Festival, Visual effects, VFX, Rock Star, EBITDA, Sumo Digital, The Mill, Take-Two Interactive, Mikros Image, Visual Effects Society, Super Bowl, Ubisoft, Euronext Paris, Agreement in principle, Film industry, Video game, Risk management, Cryptocurrency, Creative industries, Management, Renewable energy, Studio, Gameloft, Capcom

PARIS (FRANCE), March 10, 2023 – Technicolor Creative Studios (Euronext Paris: TCHCS) (the “Company”) today announced its Full Year unaudited 2022 financial results1.

Key Points: 
  • PARIS (FRANCE), March 10, 2023 – Technicolor Creative Studios (Euronext Paris: TCHCS) (the “Company”) today announced its Full Year unaudited 2022 financial results1.
  • To better seize market opportunities and strengthen Technicolor Creative Studios’ leading positions, the Company took a series of concrete measures through the Re*Imagined program.
  • I would like to express my utmost gratitude to all Technicolor Creative Studios teams, who have demonstrated relentless commitment towards delivering extraordinary work to our clients.
  • The Technicolor Games team contributed to eight global releases including FIFA 23, the biggest selling sports title of 2022.

Salvatore Zizza Named to Bion's Board of Directors

Retrieved on: 
Monday, February 6, 2023
BAM, Commerce, Pyrolysis, NYSE, Carbon, Audit committee, BNET, Livestock, Temperature, Trans-Lux, Growth, LVI, GAMCO Investors, QB, OTC, Bion, Management

NEW YORK, Feb. 6, 2023 /PRNewswire/ -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a developer of advanced livestock waste treatment technology and premium sustainable beef, announced today that Salvatore Zizza will join Bion's Board of Directors, effective February 15, 2023.

Key Points: 
  • NEW YORK, Feb. 6, 2023 /PRNewswire/ -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a developer of advanced livestock waste treatment technology and premium sustainable beef, announced today that Salvatore Zizza will join Bion's Board of Directors, effective February 15, 2023.
  • As a Board member, Mr. Zizza brings decades of experience in institutional finance, commerce, and public company practices.
  • Mr. Zizza is currently a Director of 19 funds in the Gabelli Asset Management and GAMCO Investors, Inc. fund families, including several that trade on the NYSE.
  • I look forward to contributing to those efforts by expanding the experience and expertise of the Board of Directors as the company positions itself for growth."